Franklin M. Berger founded NEMO Fund, Inc. in 2007, where he worked as Senior Manager-Portfolio from 2007 to 2008 and FMB Research in 2005, where he is working as Managing Director from 2005. Mr. Berger also currently works at Satellos Bioscience, Inc., as Director from 2023, BELLUS Health, Inc., as Independent Director from 2010, Atea Pharmaceuticals, Inc., as Lead Independent Director from 2019, and various other companies. Mr. Berger also formerly worked at Proteostasis Therapeutics, Inc., as Chairman from 2019 to 2020, Emisphere Technologies, Inc., as Director in 2009, Lineage Cell Therapeutics, Inc., as Independent Director in 2014, and various other companies.
Mr. Berger received his undergraduate degree in 1971 and graduate degree in 1972 from The Johns Hopkins University and Masters Business Admin degree in 1975 from Harvard Business School.
What is Franklin M. Berger's net worth?
The estimated net worth of Franklin M. Berger is at least $1.40 million as of December 10th, 2024. Berger owns 451,897 shares of Atea Pharmaceuticals stock worth more than $1,396,362 as of December 5th. This net worth estimate does not reflect any other assets that Berger may own. Learn More about Franklin M. Berger's net worth.
How do I contact Franklin M. Berger?
Has Franklin M. Berger been buying or selling shares of Atea Pharmaceuticals?
Franklin M. Berger has not been actively trading shares of Atea Pharmaceuticals during the last quarter. Most recently, Franklin M. Berger sold 359,606 shares of the business's stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $2.85, for a transaction totalling $1,024,877.10. Following the completion of the sale, the director now directly owns 451,897 shares of the company's stock, valued at $1,287,906.45. Learn More on Franklin M. Berger's trading history.
Who are Atea Pharmaceuticals' active insiders?
Are insiders buying or selling shares of Atea Pharmaceuticals?
During the last twelve months, insiders at the sold shares 1 times. They sold a total of 359,606 shares worth more than $1,024,877.10. The most recent insider tranaction occured on December, 10th when Director Franklin M Berger sold 359,606 shares worth more than $1,024,877.10. Insiders at Atea Pharmaceuticals own 18.1% of the company.
Learn More about insider trades at Atea Pharmaceuticals. Information on this page was last updated on 12/10/2024.
